
Danny Boyle Reveals ‘Sunshine' Was Once Planned as a Trilogy
Director Danny Boyle and screenwriter Alex Garland's zombie re-team 28 Years Later opens in a few weeks; there's already a sequel on the way, and a third film will follow if the first two excite audiences. But in a new interview, Boyle shared that 2007's Sunshine, which he made after 28 Days Later and just before his Oscar-winning Slumdog Millionaire, could have sparked another sci-fi franchise—if only it had been a bigger hit.
Sunshine has gained a cult following across the past two decades, not least because of its cast of future Oscar winners and blockbuster breakouts: Cillian Murphy, Chris Evans, Rose Byrne, Michelle Yeoh, Cliff Curtis, Mark Strong, Hiroyuki Sanada, Troy Garity, and Benedict Wong. But its tale of an international crew sent on mission to re-ignite the dying sun—dangerous enough even without a sun-crazed saboteur wreaking havoc—failed to draw crowds at the time.
Speaking to Collider, Boyle reveals what might have been, without giving too many specifics, of course. 'Originally, when we were doing it, Alex wrote two other parts. It was supposed to be a trilogy,' the director said. He clarified that Garland didn't write two other scripts; instead, he had an outline for where the story would go.
'It was a planetary trilogy. It was to do with the sun itself, with two other stories,' Boyle teased. 'What's interesting is Alex has a natural instinct as a storyteller to want to tell these expanding stories, and that is why 28 Years Later wound up as a trilogy.'
He hinted that Sunshine's sequel would have featured 'an extraordinary idea' on 'kind of Elon Musk scale, even though he's lost a lot of credibility. But it was interplanetary stuff, it had more to do with that … there's no rich man in it. But the idea of looking outside and moving.'
However, he wouldn't reveal more—out of respect to Garland, in case he ever wanted to repurpose the idea. Maybe Sunshine 2 might find life after all? Boyle's track record of long-delayed returns to his earlier films (28 Years Later, T2 Trainspotting) may give us hope yet.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Medscape
an hour ago
- Medscape
ASCO 2025: Key Highlights in Endometrial and Related Cancers
Ursula A. Matulonis, MD, shares highlights from several key studies showcasing promising developments in the treatment of endometrial cancer. A phase 2 trial led by Dr Panagiotis Konstantinopoulos evaluated a combination of letrozole, abemaciclib, and metformin in patients with estrogen receptor (ER)-positive recurrent disease, reporting promising results. In the DUO-E trial, a post hoc circulating tumor (ctDNA) analysis demonstrated that durvalumab-based therapy reduced ctDNA levels, particularly in mismatch repair-deficient tumors, with further reductions observed when olaparib was added during maintenance. Additional studies underscored therapeutic innovation: a phase 2 trial of benmelstobart, an anti-programmed death-ligand 1 (PD-L1) antibody, with or without anlotinib in combination with chemotherapy showed high response rates, and HB0025, a bispecific antibody targeting PD-L1 and VEGF, also achieved encouraging preliminary results in first-line treatment. Beyond endometrial cancer, notable progress was reported across other gynecologic malignancies. In cervical cancer, the phase 3 KEYNOTE-A18 trial confirmed the benefit of pembrolizumab plus concurrent chemoradiotherapy, significantly improving both progression-free and overall survival. In vulvar cancer, a phase 2 trial combining pembrolizumab, cisplatin, and radiation therapy showed encouraging antitumor activity. In another phase 2 trial, the HER2-directed antibody-drug conjugate SHR-A1811 demonstrated promising response rates in ovarian, endometrial, and cervical cancers. In ovarian cancer, the FIRST/ENGOT-OV44 trial did not meet its secondary endpoint with the combination of dostarlimab and niraparib maintenance over niraparib alone. However, the ROSELLA trial showed improved overall survival with the combination of relacorilant (a glucocorticoid receptor antagonist) and nab-paclitaxel in platinum-resistant disease.


Miami Herald
an hour ago
- Miami Herald
As the Beckham family feud rages on, one son just made a personal decision: report
Deep sigh. Romeo Beckham was single for a hot minute, and now has possibly moved on. David and Victoria' Beckham's middle son, 22, was just spotted with a gorgeous woman in Paris, days after reports he had split with Kim Turnbull. The latter relationship was apparently one of the catalysts for a feud currently simmering within the famous English family who lives in Miami part time. According to widespread media reports, Turnbull used to have a little something something with Romeo's older brother Brooklyn, 26. Despite being happily married to Nicola Peltz, the aspiring chef understandably didn't want to have to hang with the London-based DJ when the whole gang got together. OK, so Turnbull isn't the only cause of the alleged friction. We hear that Victoria and Peltz are not exactly besties, with problems dating back to the 'Transformers' star's 2022 wedding to the ex Spice Girl's eldest in Palm Beach. The fact that the socialite chose to wear Valentino apparently didn't sit well with her mother-in-law, a haute designer. Whatever caused the drama, and if it's still ongoing is unclear. But we do know Brooklyn recently covered up his 'Mama's Boy' chest tattoo with flowers. Ouch. Back to Romeo and his sitch: TMZ identifies his new ladyfriend as Caroline Daur, a German fitness influencer. According to her eponymous website, the 30-year-old is 'a successful self-made entrepreneur and actress' with over 4.6 million followers on Instagram. Time will tell if the Beckhams can heal from the all this tumult. Insiders tell UK's The Sun the soccer icon and former pop star are hoping they can all reunite to celebrate daughter Harper's 14th birthday, which falls on July 10. But another source threw cold water on that theory: 'It doesn't seem likely at the moment.'


Bloomberg
2 hours ago
- Bloomberg
The Best Restaurant in the UK Is in One of London's Fanciest Hotels
If you believe classic fine dining is dead, please refer to the latest UK National Restaurant Awards rankings. The Ritz London, one of the world's more classically elegant dining rooms, where chandeliers cascade from the high ceilings and the mirrored walls and sweeping shades look like they were borrowed from Versailles, ranked No. 1 on the list, which was released on Monday night. It moved up a dozen places from No. 13 last year.